KRYS logo

KRYS
Krystal Biotech Inc

1,729
Mkt Cap
$5.83B
Volume
181,030.00
52W High
$212.98
52W Low
$122.80
PE Ratio
30.92
KRYS Fundamentals
Price
$206.16
Prev Close
$201.21
Open
$199.11
50D MA
$179.87
Beta
0.91
Avg. Volume
284,899.22
EPS (Annual)
$3.00
P/B
5.25
Rev/Employee
$1.06M
Loading...
Loading...
News
all
press releases
Profund Advisors LLC Acquires 2,203 Shares of Krystal Biotech, Inc. $KRYS
Profund Advisors LLC boosted its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 36.9% during the second quarter, according to the company in its most recent disclosure...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Krystal Biotech, Inc. $KRYS Shares Bought by Los Angeles Capital Management LLC
Los Angeles Capital Management LLC increased its holdings in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 6.9% during the second quarter, according to its most recent filing with the...
MarketBeat·3d ago
News Placeholder
Krystal Biotech, Inc. $KRYS is S Squared Technology LLC's 4th Largest Position
S Squared Technology LLC grew its stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 12.3% during the 2nd quarter, according to the company in its most recent 13F filing with the...
MarketBeat·4d ago
News Placeholder
FY2025 EPS Forecast for Krystal Biotech Increased by Analyst
Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) - Stock analysts at Chardan Capital increased their FY2025 earnings per share estimates for shares of Krystal Biotech in a research note issued on...
MarketBeat·7d ago
News Placeholder
Brokers Set Expectations for Krystal Biotech FY2025 Earnings
Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) - Equities researchers at Cantor Fitzgerald upped their FY2025 EPS estimates for Krystal Biotech in a report issued on Tuesday, November 4th. Cantor...
MarketBeat·8d ago
News Placeholder
William Blair Expects Increased Earnings for Krystal Biotech
Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) - Equities researchers at William Blair upped their FY2025 earnings per share (EPS) estimates for shares of Krystal Biotech in a report released on...
MarketBeat·8d ago
News Placeholder
What's Driving the Market Sentiment Around Krystal Biotech Inc?
read more...
Benzinga·9d ago
News Placeholder
William Blair Predicts Reduced Earnings for Krystal Biotech
Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) - Research analysts at William Blair lowered their Q4 2025 earnings estimates for shares of Krystal Biotech in a report released on Monday, November...
MarketBeat·9d ago
News Placeholder
CRISPR Therapeutics AG (CRSP) Expected to Beat Earnings Estimates: Should You Buy?
CRISPR Therapeutics (CRSP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·18d ago
News Placeholder
Krystal Biotech, Inc. (KRYS) Reports Next Week: Wall Street Expects Earnings Growth
Krystal Biotech (KRYS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·19d ago

Latest KRYS News

View

Advertisement|Remove ads.

Advertisement|Remove ads.